-+ 0.00%
-+ 0.00%
-+ 0.00%

CTT Pharma wins US patent for micelle-based nicotine, vitamins, caffeine delivery technology

PUBT·08/12/2026 11:40:08
Listen to the news
CTT Pharma wins US patent for micelle-based nicotine, vitamins, caffeine delivery technology
  • CTT Pharmaceutical Holdings won a U.S. patent for a continuation-in-part covering micelle delivery technology for nicotine, vitamins, caffeine.
  • Patent issuance is scheduled for Aug. 11, 2026, with a patent number already assigned by the U.S. Patent Office.
  • Coverage supports use in dissolvable oral formats such as strips, gum, pouches, lozenges, dissolving tablets.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CTT Pharmaceutical Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171520-26-000225), on August 12, 2026, and is solely responsible for the information contained therein.